Anthony C Keech Selected Research

Venous Thromboembolism

1/2020	The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism.
1/2018	D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.
12/2012	Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony C Keech Research Topics

Disease

42	Type 2 Diabetes Mellitus (MODY) 03/2024 - 11/2006
30	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 11/2006
20	Myocardial Infarction 03/2022 - 01/2010
13	Atherosclerosis 02/2024 - 11/2006
13	Stroke (Strokes) 03/2022 - 12/2006
11	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2013
11	Coronary Disease (Coronary Heart Disease) 12/2021 - 01/2009
9	Inflammation (Inflammations) 07/2021 - 12/2008
7	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2023 - 01/2013
6	Unstable Angina 03/2022 - 10/2013
5	Diabetes Mellitus 08/2023 - 01/2020
5	Insulin Resistance 11/2020 - 08/2014
5	Hypertension (High Blood Pressure) 01/2020 - 11/2011
4	Diabetes Complications 01/2022 - 01/2009
4	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 05/2012
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 11/2006
4	Acute Coronary Syndrome 01/2020 - 11/2005
4	Dyslipidemias (Dyslipidemia) 07/2018 - 11/2006
3	Vascular Diseases (Vascular Disease) 08/2023 - 03/2015
3	Heart Failure 01/2023 - 01/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2018
3	Ischemic Stroke 12/2021 - 03/2013
3	Peripheral Arterial Disease 01/2021 - 01/2018
3	Venous Thromboembolism 01/2020 - 12/2012
3	Weight Loss (Weight Reduction) 01/2019 - 01/2018
3	Overweight 01/2019 - 01/2018
2	Kidney Diseases (Kidney Disease) 03/2024 - 01/2019
2	Atrial Fibrillation 01/2021 - 09/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 12/2012
2	Genetic Risk Score 01/2020 - 01/2020
2	Pulmonary Embolism 01/2020 - 12/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 02/2012
2	Albuminuria 01/2019 - 01/2010
2	Ischemia 01/2019 - 01/2018
2	Prediabetic State (Prediabetes) 11/2018 - 12/2017
2	Neoplasms (Cancer) 01/2018 - 05/2016
2	Pancreatitis 12/2017 - 08/2012
2	Body Weight (Weight, Body) 04/2015 - 01/2015
1	Dementia (Dementias) 08/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2023
1	Intermittent Claudication 01/2021

Drug/Important Bio-Agent (IBA)

38	Fenofibrate (CiL)FDA LinkGeneric 03/2024 - 11/2006
21	evolocumabIBA 01/2022 - 01/2017
16	LipidsIBA 07/2018 - 11/2006
15	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 11/2006
15	LDL CholesterolIBA 10/2021 - 03/2013
11	Insulin (Novolin)FDA Link 07/2023 - 01/2010
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2008
8	Proprotein Convertase 9IBA 01/2022 - 10/2017
7	CholesterolIBA 12/2020 - 11/2011
6	fibroblast growth factor 21IBA 02/2024 - 12/2012
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2014
6	oxidized low density lipoproteinIBA 10/2021 - 07/2016
6	CreatinineIBA 11/2020 - 06/2009
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 12/2012
5	Retinaldehyde (Retinal)IBA 11/2023 - 01/2013
5	Triglycerides (Triacylglycerol)IBA 11/2020 - 11/2011
5	Pravastatin (Pravachol)FDA LinkGeneric 01/2018 - 10/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
3	Uric Acid (Urate)IBA 01/2021 - 01/2018
3	HomocysteineIBA 11/2020 - 06/2009
3	HDL LipoproteinsIBA 01/2020 - 03/2013
3	HDL CholesterolIBA 01/2020 - 06/2009
3	C-Reactive ProteinIBA 01/2020 - 05/2016
3	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2013
3	lorcaserinIBA 01/2019 - 01/2018
2	omega-Chloroacetophenone (Mace)IBA 03/2022 - 01/2021
2	TroponinIBA 01/2022 - 01/2020
2	CarbohydratesIBA 09/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Colchicine FDA LinkGeneric 01/2021 - 01/2020
2	TicagrelorIBA 01/2021 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2021
2	saxagliptin FDA Link 01/2021 - 01/2021
2	Fatty Acid-Binding ProteinsIBA 11/2020 - 12/2012
2	AlbuminsIBA 01/2019 - 11/2014
2	Troponin IIBA 01/2018 - 02/2014
2	Therapeutic UsesIBA 10/2014 - 01/2013
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2014 - 06/2009
2	Fibric Acids (Fibrates)IBA 08/2012 - 11/2006
1	Myeloblastin (Proteinase 3)IBA 07/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 07/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	mirabegronIBA 01/2021
1	darapladibIBA 01/2021
1	C-PeptideIBA 01/2021
1	LeptinIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 12/2020

Therapy/Procedure

25	Therapeutics 01/2023 - 02/2012
6	Surgical Amputation (Amputations) 12/2021 - 01/2009
4	Injections 09/2021 - 01/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2020
2	Glycemic Control 12/2021 - 05/2012
2	Lasers (Laser) 04/2015 - 12/2013
2	Renal Dialysis (Hemodialysis) 02/2012 - 01/2009
1	Secondary Prevention 01/2023
1	Percutaneous Coronary Intervention 01/2022
1	Cerebral Revascularization 12/2021